Our Funds
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
Accelerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017. Currently open for investment.
Our Funds
Seed Fund I
Established a portfolio of early stage medical device companies that looked to solve real problems.
Seed Fund II
Created investment opportunities that allowed direct engagement into company operations.
Accelerator
Continued investing in technologies that improve outcomes & reduce healthcare system costs.
Opportunity
The Opportunity Fund leverages the foundation that the cultivate(MD) Seed and Accelerator Funds have built since 2017.
Representative Investments
Embody
Embody, Inc., is a regenerative medicine company focused on the development and commercialization of implantable medical devices to address the unmet demands in soft tissue restoration and regeneration.
Imascap
Imascap develops software for preoperative planning of shoulder replacement surgery.
Shoulder Innovations
Shoulder Innovations’ InSet™ Total Shoulder Replacement System addresses the most significant issue in shoulder arthroplasty: unreliable fixation of the glenoid implant.
News and Updates
cultivate(MD) Announces Portfolio Company, Virtual Incision Corporation, Appoints Jim Alecxih as Chief Executive Officer
GRAND RAPIDS, MI – June 24, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce that its portfolio company, Virtual Incision Corporation, the developer of the
HAPPE Spine Selected for MedTech Innovator 2025 Accelerator Cohort
We’re proud to share that HAPPE Spine, a portfolio company of cultivate(MD), has been selected for the MedTech Innovator 2025 Accelerator Cohort, an honor reserved
cultivate(MD) Announces Acquisition of Portfolio Company SPDx by Instrumentum
Grand Rapids, MI – June 11, 2025 – cultivate(MD), a leading medical device venture capital company, is pleased to announce the acquisition of its portfolio company, Sterile Processing
Dr. Sean Churchill, MBA Joins Nanochon’s ChonChats
Nanochon, a cultivate(MD) portfolio company, has launched a new podcast titled “ChonChats,” hosted by Benjamin Holmes and Rachel Offenburg. The inaugural episode features R. Sean
Virtual Incision to Explore Nvidia AI for Surgical Robotics
Virtual Incision, a cultivate(MD) portfolio company, has announced plans to explore the use of Nvidia Isaac for Healthcare to advance next-generation surgical robotics. The company
Shoulder Innovations Announces Closing of $40 Million Series E Equity Financing
Grand Rapids, MI – March 10, 2025 – Shoulder Innovations, a cultivate(MD) portfolio company, and a leader in shoulder replacement technology, today announced the closing of a